GSDMD and osteosarcoma: The expression of GSDMD is significantly upregulated in osteosarcoma and is associated with drug resistance and poor prognosis in osteosarcoma patients, providing new insights into the diagnosis and prognosis prediction of osteosarcoma (71, 124).